% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{Galldiks:288867,
      author       = {N. Galldiks and T. J. Kaufmann and P. Vollmuth and P.
                      Lohmann and M. Smits and M. C. Veronesi and K.-J. Langen and
                      R. Rudá and N. L. Albert$^*$ and E. Hattingen and I. Law
                      and M. Hutterer and R. Soffietti and M. A. Vogelbaum and P.
                      Y. Wen and M. Weller and J.-C. Tonn$^*$},
      title        = {{C}hallenges, {L}imitations and {P}itfalls of {PET} and
                      {A}dvanced {MRI} in {P}atients with {B}rain {T}umors - {A}
                      {R}eport of the {PET}/{RANO} {G}roup.},
      journal      = {Neuro-Oncology},
      volume       = {26},
      number       = {7},
      issn         = {1522-8517},
      address      = {Oxford},
      publisher    = {Oxford Univ. Press},
      reportid     = {DKFZ-2024-00514},
      pages        = {1181-1194},
      year         = {2024},
      note         = {2024 Jul 5;26(7):1181-1194},
      abstract     = {Brain tumor diagnostics have significantly evolved with the
                      use of PET and advanced MRI techniques. In addition to
                      anatomical MRI, these modalities may provide valuable
                      information for several clinical applications such as
                      differential diagnosis, delineation of tumor extent,
                      prognostication, differentiation between tumor relapse and
                      treatment-related changes, and the evaluation of response to
                      anticancer therapy. In particular, joint recommendations of
                      the RANO group, the EANO, and major European and American
                      Nuclear Medicine societies highlighted that the additional
                      clinical value of radiolabeled amino acids compared to
                      anatomical MRI alone is outstanding and that its widespread
                      clinical use should be supported. For advanced MRI and its
                      steadily increasing use in clinical practice, the
                      Standardization Subcommittee of the Jumpstarting Brain Tumor
                      Drug Development Coalition provided more recently an updated
                      acquisition protocol for the widely used dynamic
                      susceptibility contrast perfusion MRI. Besides amino acid
                      PET and perfusion MRI, other PET tracers and advanced MRI
                      techniques (e.g., MR spectroscopy) are of considerable
                      clinical interest and are increasingly integrated into
                      everyday clinical practice. Nevertheless, these modalities
                      have shortcomings which should be considered in clinical
                      routine. This comprehensive review provides an overview of
                      potential challenges, limitations and pitfalls associated
                      with PET imaging and advanced MRI techniques in patients
                      with gliomas or brain metastases. Despite these issues, PET
                      imaging and advanced MRI techniques continue to play an
                      indispensable role in brain tumor management. Acknowledging
                      and mitigating these challenges through interdisciplinary
                      collaboration, standardized protocols, and continuous
                      innovation will further enhance the utility of these
                      modalities in guiding optimal patient care.},
      keywords     = {CEST (Other) / MR spectroscopy (Other) / amino acid PET
                      (Other) / diffusion-weighted imaging (Other) /
                      perfusion-weighted imaging (Other)},
      cin          = {MU01},
      ddc          = {610},
      cid          = {I:(DE-He78)MU01-20160331},
      pnm          = {899 - ohne Topic (POF4-899)},
      pid          = {G:(DE-HGF)POF4-899},
      typ          = {PUB:(DE-HGF)16},
      pubmed       = {pmid:38466087},
      doi          = {10.1093/neuonc/noae049},
      url          = {https://inrepo02.dkfz.de/record/288867},
}